LONG-TERM EFFICACY AND SAFETY PROFILE OF EZETIMIBE10MG IN TREATMENT OF PATIENTS WITH HOMOZYGOUS SITOSTEROLEMIA: A MULTI-CENTER, OPEN-LABEL, 2-YEAR EXTENSION STUDY

被引:0
|
作者
Luetjohann, D. [1 ]
von Bergmann, K. [1 ]
Sirah, W. [2 ]
Shah, A. [2 ]
Lin, J. [2 ]
Sapre, A. [2 ]
Johnson-Levonas, A. [2 ]
Musliner, T. [2 ]
机构
[1] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany
[2] Merck Res Labs, Rahway, NJ USA
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:189 / 189
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of lurasidone in adolescents with schizophrenia: Results of a 2-year, open-label extension study
    Goldman, R.
    Correll, C.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S89
  • [22] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [23] Long-Term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: 2-year results from the NEURO-TTR open-label extension study
    Brannagan, T.
    Waddington Cruz, M.
    Wang, A. K.
    Polydefkis, M. J.
    Dyck, P. J.
    Khella, S.
    Plante-Bordeneuve, V.
    Berk, J. L.
    Barroso, F.
    Merlini, G.
    Conceicao, I.
    Hughes, S. G.
    Kwoh, J.
    Jung, S. W.
    Guthrie, S.
    Pollock, M.
    Benson, M. D.
    Gertz, M.
    Coelho, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 92 - 92
  • [24] Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial
    Ako, Junya
    Yokote, Koutaro
    Tsujita, Kenichi
    Tanigawa, Ryohei
    Kamei, Ryo
    Suganami, Hideki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (03) : 288 - 305
  • [25] Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: An open-label extension study
    Garber, AJ
    Bruce, S
    Fiedorek, FT
    CLINICAL THERAPEUTICS, 2002, 24 (09) : 1401 - 1413
  • [26] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [27] Long-term darifenacin treatment for overactive bladder: Quality of life outcomes from a 2-year, open-label extension study
    Young, J
    Lheritier, K
    Steel, M
    Dwyer, P
    VALUE IN HEALTH, 2005, 8 (06) : A85 - A86
  • [28] QOL OUTCOMES DURING LONG-TERM TREATMENT WITH DARIFENACIN FOR OVERACTIVE BLADDER (OAB): A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Young, Jay
    Lheritier, Karine
    Steel, Michael
    Dwyer, Peter
    QUALITY OF LIFE RESEARCH, 2005, 14 (09) : 2036 - 2036
  • [29] Long-term persistence and compliance with darifenacin treatment for overactive bladder: results of a 2-year open-label extension study.
    Hill, S
    Lheritier, K
    Kawakami, F
    PHARMACOTHERAPY, 2005, 25 (10): : 1493 - 1493
  • [30] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine I.
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rizo Rodriguez, Juan Cruz
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571